on August 29, 2012 |
Permalink
Topics: Capital Planning, Finance, Imaging, Service Lines, Planning, Strategy, Technology Assessment
Matthew Morril, Technology Insights
While demographic trends are placing a larger burden on hospital resources, capital budgets continue to tighten in the wake of reform. Administrators may seek to control costs by extending the useful lives of clinical technology and equipment, which could save millions of dollars if done prudently and deliberately.
However, hospital administrators must be cautious to find the balance between conserving capital and meeting the clinical standard of care by offering key innovations. Ultimately, administrators must balance several factors—such as cost of maintenance, downtime, and tradeoffs in technological advances—when making decisions to extend the lifecycles of their imaging equipment.
Continue reading:
In case you missed it: Maximizing your imaging equipment lifecycles
on February 14, 2011 |
Permalink
Topics: Imaging, Service Lines, Technology Assessment, Planning, Strategy, Reimbursement, Finance
Medtronic has announced the approval of its Revo MRI SureScan magnetic resonance imaging (MRI)-compatible pacemaker, the first pacemaker in the U.S. that is designed specifically for use in an MRI environment. This approval is expected to significantly boost the device market in the coming year due to the roughly 200,000 U.S. pacemaker patients who currently must forego an MRI. The Revo MRI SureScan--which is priced at a comparable level as other pacemakers (ranging from $5,000 to $10,000)--contains two CapSureFix MRI leads and comes with a function that can be turned on before patients receive an MRI to prepare them for the scan. The device, however, is classified as "MR-conditional," meaning that it can be used in an MRI environment only under certain conditions, such as if a patient has never received a lead or pacemaker previously and if an MRI system has a static magnetic field of 1.5 Tesla.
Continue reading:
First U.S. MRI-Compatible Pacemaker Approved, Though Reimbursement a Challenge
on February 11, 2011 |
Permalink
Topics: Imaging, Service Lines, Technology Assessment, Planning, Strategy, Mammography
It's been 5 long years since we first learned of and reported on Digital Breast Tomosynthesis - an exciting new breast imaging technology that could revolutionize mammography. And now, the time has finally come for the much-awaited, highly controversial technology. Just hours ago, the FDA approved Hologic's Selenia Dimensions digital mammography system for 3D breast tomosynthesis, becoming the first vendor to offer the 3D mammography technique in the United States.
Continue reading:
Hologic's 3D Digital Breast Tomosynthesis Receives FDA Approval
